NCT03963544 2025-12-10
METAGIST
Institut Bergonié
Completed
Clinical Trials
10 trialsNCT04151342 2025-12-03
CARMA-BROS
University Health Network, Toronto
Recruiting
NCT03958565 2025-05-21
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
University of Colorado, Denver
Recruiting
NCT06858956 2025-03-05
Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT06682247 2024-11-12
A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer
Sun Yat-sen University
Not yet recruiting
NCT06632106 2024-10-08
HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC
First Hospital of China Medical University
Active not recruiting
NCT04375150 2024-09-19
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
Pfizer
Completed
NCT06121765 2023-11-08
Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI
Assiut University
Unknown
NCT05476562 2022-11-08
Study Conducted Among Patients With CML
Novartis
Completed
NCT01098500 2017-05-30
Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs
GlaxoSmithKline
Completed